ADVERTISEMENT
40th Anniversary of PTCA
International Andreas Gruentzig Society Meeting
Zurich, Switzerland: September 18‐19, 2017
Stresa, Italy: September 21‐22, 2017
40th Anniversary of PTCA
Faculty Disclosure
Vendor Acknowledgment
Detailed Program Agenda
Program Agenda
Scientific Sessions
Welcome & Introductions
Gary Roubin, Stephan Windecker, Thomas Lüscher
_____________
Historical Perspectives
History of Coronary PTCA in Europe: It Began Here
Speaker: Bernhard Meier
_____________
History of PTCA in the United States
Speaker: Spencer King
_____________
History of Coronary Stenting: More or Less
Speaker: Patrick Serruys
_____________
Primary PCI: The Most Valuable Contribution We Made
Speaker: Jorge Belardi
_____________
Lessons Learned from Failed Interventions
Speaker: Stephan Windecker
_____________
Plaque Modification: The Key to Complex Intervention
Speaker: Michael Cowley
_____________
Physiologic Guidance of Coronary Intervention: From Balloon Pressure Gradients to CT-FFR
Speaker: Pierre Leimgruber
_____________
Image Guidance of Coronary Intervention: Define the Clinical Value
Speaker: Kirk Garratt
_____________
Atherectomy: Making a Comeback Thanks to BVS, DCB and ISR
Speaker: Cindy Grines
_____________
Lower-Extremity Intervention: From Dottering to DCBs: Are We Going in the Right Direction?
Speaker: Lawrence Garcia
_____________
Acute Stroke Intervention: Now It’s Hot
Speaker: Gyula Gal
_____________
Carotid Intervention: Where Do We Go From Here?
Speaker: Gary Roubin
Dr Roubin was scheduled to speak during the Historical Perspectives sessions on 9/18 but had travel delays and spoke during the Coronary Session 1 on 9/19 instead. His entire speech is therefore unavailable, but his presentation was discussed in the day's Summary Session.
_____________
Coronary
SESSION SUMMARY: Bioresorbable Stents
SESSION SUMMARY: Left Main PCI
SESSION SUMMARY: Pharmacotherapy for Atherosclerotic Regression
SESSION SUMMARY: COMPLETE Revascularization in STEMI: How Far do We Go?
SESSION SUMMARY: Robotic PCI
_____________
Structural
SESSION SUMMARY: TAVR in Low-Risk Patients
SESSION SUMMARY: How to Predict Who Benefits in Patients with Low Flow Low Gradient AS and LV Dysfunction
SESSION SUMMARY: Alcohol Septal Ablation
SESSION SUMMARY: Transcatheter Mitral Valve Repair / TMVR (Tendyne, Twelve, Tiara, etc.)
SESSION SUMMARY: Interventional Treatment of the Tricuspid Valve
_____________
Hemodynamics
SUMMARY SESSION: Hemodynamic Support for AMI With Cardiogenic Shock
SUMMARY SESSION: Percutaneous LVADs and RVADs for Heart Failure: No More Drips?
SUMMARY SESSION: Interventional and Surgical Therapies for Massive PE: What's PERTinent?
_____________
Special Session on Prevention of Cardioembolic Stroke
SESSION SUMMARY: PFO Closure: Who Do We Close Today?
SESSION SUMMARY: LAA Closure: Mainstream or Niche?
SESSION SUMMARY: Arch Protection for Structural Interventions: A Filtered Claret?
SESSION SUMMARY: Antiplatelet Therapy in Patients Undergoing Structural Heart or Coronary Interventions with Afib and High CHADS‐Vasc Scores
_____________
Emerging Therapies
SUMMARY SESSION: New Devices For Coronary CTOs: Soundbites on Plasma Wires
SUMMARY SESSION: New Frontiers in Radial Intervention: Will They Lead to More Complete Adoption?
SUMMARY SESSION: Bioerodable Metallic Scaffolds
_____________
Industry
SUMMARY SESSION: How Did We Get From Indicated to Not Medically Necessary and/or Rarely Appropriate?
SUMMARY SESSION: How to Determine the Economic Value of Interventions?
SUMMARY SESSION: How Do Physicians Maintain a Voice in the Rapidly Evolving Consolidation of Health Care Delivery?
